跳至主要内容
临床试验/ITMCTR2000003150
ITMCTR2000003150招募中4 期

Gu-Shen Ding-Chuan-Wan used in the recovery phase of 2019-nCoV pneumonia(FeiPiQiXuZheng): a randomized, open-label, controlled clinical trial

The First Affiliated Hospital of Guangzhou Medical University0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • (1) Aged >=18 years;
  • (2) 2019-nCoV pneumonia is diagnosed according to the standard of diagnosis and treatment;
  • (3) Patient's condition has reached the standard of desolation / discharge specified according to the diagnosis and treatment plan;
  • (4) According to the diagnosis standard, the syndrome differentiation of TCM is FeiPiQiXuZheng;
  • (5) Volunteer to participate in the study and sign informed consent.

排除标准

  • (1) Known or suspected allergy to the components of the study drug;
  • (2) Acute infection of other viruses and bacteria has not been cured;
  • (3) The function of liver and kidney was abnormal (ALT/AST>=2 times of the upper limit of normal value, SCr>1.5 times of the upper limit of normal value);
  • (4) Participating in clinical trials of other drugs;
  • (5) Pregnant and lactating women; or can not take effective contraceptive measures during the trial;
  • (6) According to the judgment of the researcher, there are other situations that are not suitable for the experiment.

研究者

发起方
The First Affiliated Hospital of Guangzhou Medical University

相似试验